The drug regulatory authorities authorised Reliance Life Sciences’ proposal to conduct clinical trials of its recombinant protein-based Covid-19 vaccine candidate on Thursday. Reliance Life Sciences is part of India’s largest private-sector organisation. Reliance had requested permission from the agency to undertake a Phase 1 trial of its proposed two-dose Continue Reading
